Yakira Capital Management’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Yakira Capital Management’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-127,497	Closed	-$10K	–	489
2022 Q2	$10K	Hold	127,497	–	–	﹤0.01%	368
2022 Q1	$19K	Hold	127,497	–	–	﹤0.01%	410
2021 Q4	$37K	Sell	127,497 -16,600	-12%	-$8.49K	﹤0.01%	376
2021 Q3	$108K	Sell	144,097 -100,903	-41%	-$76.1K	0.02%	301
2021 Q2	$184K	Buy	+245,000	New	+$154K	0.03%	272

Other funds holding CRXTW

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Yakira Capital Management's CRXTW Position: Q3 2022 in Review

Yakira Capital Management sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q3 2022, closing a stake of 127,497 shares — an estimated $10K sold.

Yakira Capital Management first reported a position in CRXTW in Q2 2021 and held it in 5 quarters. The position peaked at $184K in Q2 2021. 5 funds tracked by Wall St. Rank hold CRXTW as of Q3 2022.

Yakira Capital Management reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q3 2022 after selling out during the quarter.
Yakira Capital Management sold 127,497 Clarus Therapeutics Holdings, Inc. Warrants shares in Q3 2022, an estimated $10K.
Yakira Capital Management first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q2 2021 and held it in 5 quarters.
Yakira Capital Management's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $184K in Q2 2021.
5 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q3 2022.

Based on Yakira Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.